Veru Enrolls First Patient in Phase 3 VERACITY Clinical Trial of Sabizabulin (VERU-111) in Metastatic Castration Resistant and Androgen Receptor Targeting Agent Resistant Prostate Cancer

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

Suma Ramadas, PhD
Medical Affairs

Bud Bilanich
Success Coach

Harshit Jain, MD
Programmatic Marketing

Joey Cohen
Medication Adherence

Paul Theisen
Patient Acquisition

Matthew Durham
Omnidynamic Marketing

Frank Burrell
Scientific Storytelling